{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:36:44Z","timestamp":1789763804270,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0906300"],"award-info":[{"award-number":["2016YFC0906300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011366"],"award-info":[{"award-number":["2019A1515011366"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013092","name":"Science and Technology Planning Project of Fuzhou","doi-asserted-by":"publisher","award":["202102020557"],"award-info":[{"award-number":["202102020557"]}],"id":[{"id":"10.13039\/501100013092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["KF202202"],"award-info":[{"award-number":["KF202202"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2019B030316001"],"award-info":[{"award-number":["2019B030316001"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801343"],"award-info":[{"award-number":["81801343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.schres.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:05:57Z","timestamp":1710493557000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia"],"prefix":"10.1016","volume":"267","author":[{"given":"Shuyun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2024.03.002_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/09540261.2010.515205","article-title":"Sex differences in schizophrenia","volume":"22","author":"Abel","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2006.02.008","article-title":"Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia","volume":"84","author":"Akhondzadeh","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0091-3057(98)00188-9","article-title":"Antipsychotic drugs and reproductive hormones: relationship to body weight regulation","volume":"62","author":"Baptista","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2024.03.002_bb0020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S0033291707000578","article-title":"Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia","volume":"37","author":"Bergemann","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2024.03.002_bb0025","first-page":"693","article-title":"Schizophrenia and sex hormones: what is the link?","volume":"11","author":"Brzezinski-Sinai","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2024.03.002_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0278-5846(84)80028-7","article-title":"Gonadotropin response to gonadotropin releasing hormone in acute schizophrenia","volume":"8","author":"Cantalamessa","year":"1984","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/bmj.2.6039.784","article-title":"Hormonal profiles after the menopause","volume":"2","author":"Chakravarti","year":"1976","journal-title":"Br. Med. J."},{"key":"10.1016\/j.schres.2024.03.002_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.03.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004719.pub2","article-title":"Estrogen for schizophrenia","author":"Chua","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2024.03.002_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S2215-0366(15)00003-6","article-title":"New perspectives on schizophrenia in later life: implications for treatment, policy, and research","volume":"2","author":"Cohen","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.07.002","article-title":"Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis","volume":"114","author":"Cotton","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF00637379","article-title":"Trait anxiety, submaximal physical exercise and blood androgens","volume":"58","author":"Diamond","year":"1989","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.schres.2024.03.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230674","article-title":"Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom","volume":"15","author":"Dregan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2024.03.002_bb0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.1983.01790060053007","article-title":"Anterior pituitary hormone secretion in chronic schizophrenics: responses to Administration of Hypothalamic Releasing Hormones","volume":"40","author":"Ferrier","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2019.01.015","article-title":"The efficacy of cariprazine in negative symptoms of schizophrenia: post hoc analyses of PANSS individual items and PANSS-derived factors","volume":"58","author":"Fleischhacker","year":"2019","journal-title":"Eur. psychiatr."},{"key":"10.1016\/j.schres.2024.03.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173895","article-title":"Gender-specific approach in psychiatric diseases: because sex matters","volume":"896","author":"Franceschini","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2024.03.002_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/615356","article-title":"A role for estrogen in schizophrenia: clinical and preclinical findings","volume":"2015","author":"Gogos","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.schres.2024.03.002_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00737-017-0757-2","article-title":"Do FSH\/LH ratio and gonadal hormone levels predict clinical improvement in postmenopausal schizophrenia women?","volume":"20","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2017","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.schres.2024.03.002_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1314.042","article-title":"Negative correlation between negative symptoms of schizophrenia and testosterone levels","volume":"1032","author":"Goyal","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2024.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.psyneuen.2010.12.018","article-title":"Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia","volume":"36","author":"Guest","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2024.03.002_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia","volume":"28","author":"H\u00e4fner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.psychres.2017.06.024","article-title":"Men and women with psychosis and the impact of illness-duration on sex-differences: the second Australian national survey of psychosis","volume":"256","author":"Hanlon","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.158.7.1134","article-title":"Association of estrogen levels with neuropsychological performance in women with schizophrenia","volume":"158","author":"Hoff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0306-4530(00)00034-2","article-title":"Estradiol levels in psychotic disorders","volume":"26","author":"Huber","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1600-0447.2003.00251.x","article-title":"Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis","volume":"109","author":"Huber","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2024.03.002_bb0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/ijms22010373","article-title":"The role of estrogen receptors and their signaling across psychiatric disorders","volume":"22","author":"Hwang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2024.03.002_bb0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2024.03.002_bb0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","article-title":"Epidemiology of puerperal psychoses","volume":"150","author":"Kendell","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.psyneuen.2007.02.002","article-title":"Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia","volume":"32","author":"Ko","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0150","first-page":"8","article-title":"The Mini-mental state examination (MMSE)","volume":"25","author":"Kurlowicz","year":"1999","journal-title":"J. Gerontol. Nurs."},{"key":"10.1016\/j.schres.2024.03.002_bb0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14656566.2017.1288722","article-title":"How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review","volume":"18","author":"Lange","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.schres.2024.03.002_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajp.2010.11.005","article-title":"Gender differences in Singaporean Chinese patients with schizophrenia","volume":"4","author":"Lee","year":"2011","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2024.03.002_bb0165","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/PSY.0000000000000998","article-title":"Sex difference in comorbid depression in first-episode and drug-naive patients with schizophrenia: baseline results from the depression in schizophrenia in China study","volume":"83","author":"Li","year":"2021","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.schres.2024.03.002_bb0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.ps.201400032","article-title":"Schizophrenia-related disability in China: prevalence, gender, and geographic location","volume":"66","author":"Liu","year":"2015","journal-title":"PS"},{"key":"10.1016\/j.schres.2024.03.002_bb0175","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the north American trials","volume":"9","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11154-011-9184-2","article-title":"Sex steroids and schizophrenia","volume":"13","author":"Markham","year":"2012","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.schres.2024.03.002_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yfrne.2017.06.003","article-title":"Estrogens and the cognitive symptoms of schizophrenia: possible neuroprotective mechanisms","volume":"47","author":"McGregor","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.schres.2024.03.002_bb0190","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2011.10060907","article-title":"Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study","volume":"168","author":"Meltzer","year":"2011","journal-title":"AJP"},{"key":"10.1016\/j.schres.2024.03.002_bb0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2009.009102","article-title":"Oestradiol assays: fitness for purpose?","volume":"46","author":"Middle","year":"2009","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.schres.2024.03.002_bb0200","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.psyneuen.2013.02.007","article-title":"Serum testosterone levels are related to cognitive function in men with schizophrenia","volume":"38","author":"Moore","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0205","article-title":"Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.schres.2024.03.002_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O\u2019Keane","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.03.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12446","article-title":"Gender differences in socio-demographics, clinical characteristic and quality of life in patients with schizophrenia: a community-based study in Shenzhen","volume":"13","author":"Peng","year":"2021","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0220","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/healthcare10122366","article-title":"Mortality in schizophrenia-Spectrum disorders: recent advances in understanding and management","volume":"10","author":"Peritogiannis","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.schres.2024.03.002_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2296-9-29","article-title":"The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: a prospective observational study","volume":"9","author":"Pezzotti","year":"2008","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.schres.2024.03.002_bb0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00005053-200010000-00003","article-title":"Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders","volume":"188","author":"Purnine","year":"2000","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2024.03.002_bb0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00737-019-0952-4","article-title":"Change of symptoms of schizophrenia across phases of menstrual cycle","volume":"23","author":"Ray","year":"2020","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.schres.2024.03.002_bb0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02190244","article-title":"Schizophrenia and oestrogens--is there an association?","volume":"242","author":"Riecher-R\u00f6ssler","year":"1993","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.03.002_bb0245","article-title":"Gender aspects in schizophrenia: bridging the border between social and biological psychiatry","volume":"58\u201362","author":"Riecher-R\u00f6ssler","year":"2000","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2024.03.002_bb0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00449905","article-title":"Effects of 4 weeks treatment with chlorpromazine and\/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics","volume":"237","author":"Rinieris","year":"1988","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.schres.2024.03.002_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JAD-2008-13304","article-title":"Gonadotropins and cognition in older women","volume":"13","author":"Rodrigues","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.schres.2024.03.002_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2010.09.014","article-title":"Peripheral oxytocin is associated with reduced symptom severity in schizophrenia","volume":"124","author":"Rubin","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0265","first-page":"130","article-title":"Relationship between gonadal hormone levels and symptom severity in female patients with schizophrenia","volume":"22","author":"Sezer","year":"2021","journal-title":"Alpha Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.schres.2024.03.002_bb0270","first-page":"22","article-title":"The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0275","series-title":"proceedings of the VI International AROMATASE conference \u201cAROMATASE 200\u201d","first-page":"225","article-title":"Sources of estrogen and their importance. The journal of steroid biochemistry and molecular biology","volume":"86","author":"Simpson","year":"2003"},{"key":"10.1016\/j.schres.2024.03.002_bb0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/08039488.2014.947320","article-title":"Testosterone levels and clinical features of schizophrenia with emphasis on negative symptoms and aggression","volume":"69","author":"Sisek-\u0160prem","year":"2015","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0285","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09540261.2010.515965","article-title":"Gender differences in antipsychotic prescribing","volume":"22","author":"Smith","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004714-200204000-00002","article-title":"The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis","volume":"22","author":"Smith","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.03.002_bb0295","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1176\/appi.ajp.159.5.713","article-title":"Schizophrenia: reproductive hormones and the brain","volume":"159","author":"Stevens","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0300","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1214\/aos\/1074290335","article-title":"The positive false discovery rate: a Bayesian interpretation and the q-value","volume":"31","author":"Storey","year":"2003","journal-title":"Ann. Stat."},{"key":"10.1016\/j.schres.2024.03.002_bb0305","first-page":"141","article-title":"Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology","volume":"6","author":"Strous","year":"2005","journal-title":"Essent. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.03.002_bb0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","article-title":"Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia","volume":"60","author":"Strous","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psyneuen.2006.11.002","article-title":"Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial","volume":"32","author":"Strous","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0320","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2007.05.025","article-title":"Gender differences in 542 Chinese inpatients with schizophrenia","volume":"97","author":"Tang","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112510","article-title":"Dissecting the syndrome of schizophrenia: associations between symptomatology and hormone levels in women with schizophrenia","volume":"280","author":"Thomas","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.03.002_bb0335","first-page":"395","article-title":"Temporal variations in androgens and stress hormones in control and schizophrenic subjects","volume":"14","author":"Tourney","year":"1979","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0340","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, Neuroinflammation, and Neurodegeneration","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.schres.2024.03.002_bb0345","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2024.03.002_bb0350","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.57.12.1157","article-title":"Alteration in the hypothalamic-pituitary-ovarian Axis in depressed women","volume":"57","author":"Young","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2024.03.002_bb0355","first-page":"2155","article-title":"Correlations between hormone levels and psychiatric symptoms as well as cognitive function in drug-free first-episode schizophrenics","volume":"96","author":"Yuan","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.schres.2024.03.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.105061","article-title":"Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia","volume":"124","author":"Zhou","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2024.03.002_bb0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12974-021-02261-5","article-title":"Sex difference in the interrelationship between TNF-\u03b1 and oxidative stress status in first-episode drug-na\u00efve schizophrenia","volume":"18","author":"Zhu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.schres.2024.03.002_bb0370","first-page":"59","article-title":"Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial","volume":"9","author":"Zhu","year":"2022","journal-title":"Mil. Med. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:23:34Z","timestamp":1778581414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996424000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":74,"alternative-id":["S0920996424000951"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2024.03.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}